Investment 15 February 2026

Rolls-Royce Shares Jump 10% as Ceasefire Rally Puts Buyback Back in Focus

Rolls-Royce Shares Jump 10% as Ceasefire Rally Puts Buyback Back in Focus

Rolls-Royce Holdings shares surged 10% to 1,257.1 pence on Wednesday after a U.S.-Iran ceasefire lifted London markets and a filing showed ongoing share buybacks. Morgan Stanley purchased 736,316 shares for cancellation on April 7, bringing total repurchases to nearly 29 million. The FTSE 100 rose 2.9% by 1042 GMT as Brent crude fell 12.3% on hopes of resumed shipping through the Strait of Hormuz.
April 8, 2026
Croda share price dips to 3,056p — what CRDA investors are watching before Feb 24 results

Croda share price dips to 3,056p — what CRDA investors are watching before Feb 24 results

Croda shares closed at 3,056p on Friday, down 2.46%, underperforming a rising FTSE 100. JPMorgan this week raised its price target to 4,000p and reiterated an “overweight” rating ahead of Croda’s full-year 2025 results due Feb. 24. CEO Steve Foots and other executives bought shares at 3,100p on Feb. 10. Trading volumes ran above the 50-day average.
February 15, 2026
ICG share price ends Friday higher at 1,704p as UK asset-manager deal talk returns

ICG share price ends Friday higher at 1,704p as UK asset-manager deal talk returns

ICG shares closed up 0.18% at 1,704 pence Friday as the FTSE 100 gained 0.4% for a third straight weekly rise. About 2.3 million ICG shares traded, with the 52-week range at 1,539–2,468 pence. ICG reported $127 billion in assets under management at year-end, with $85 billion fee-earning. Next milestones are a March 24 shareholder seminar and May 21 full-year results.
February 15, 2026
Centrica share price: what to watch before Feb 19 results and Ofgem’s Feb 25 price-cap call

Centrica share price: what to watch before Feb 19 results and Ofgem’s Feb 25 price-cap call

Centrica shares closed down 0.98% at 191.45p in London, with 37.5 million shares traded. The British Gas owner will report full-year results on Feb 19, ahead of Ofgem’s Feb 25 energy price cap decision for April-June. Centrica also announced a £2.4 million partnership with The Multibank charity. The company will shift to adjusted EBITDA as its main guidance metric from 2025.
February 15, 2026
SSE share price near a 52-week high as BoE rate debate sharpens — what to watch next

SSE share price near a 52-week high as BoE rate debate sharpens — what to watch next

SSE closed Friday up 0.99% at 2,641p, near a 52-week high, after Fitch affirmed its BBB+ rating with a stable outlook. Around 7.5 million shares traded. Investors await the March 3 network price control decision and full-year results on May 28. The FTSE 100 rose 0.4% as markets priced in a possible Bank of England rate cut, though officials signaled caution.
February 15, 2026
Barclays share price slides to 454p ahead of Monday: buyback, rate bets and UK bank earnings in focus

Barclays share price slides to 454p ahead of Monday: buyback, rate bets and UK bank earnings in focus

Barclays closed Friday at 454p, down 2.07%, with trading volume above its 50-day average and the stock about 10% below its Feb. 4 high. The bank has repurchased over 7.2 million shares since its buyback began, at an average price of 480.44p. Chairman Nigel Higgins bought 6,769 shares at 480.8p. The Bank of England’s next rate decision is set for March 19, with Bank Rate at 3.75%.
February 15, 2026
GSK share price set for ex-dividend week after Friday rise — what investors watch next

GSK share price set for ex-dividend week after Friday rise — what investors watch next

GSK shares closed Friday up 1.1% at 2,161 pence, ahead of a Feb. 19 ex-dividend date for its 18 pence Q4 payout. The company reaffirmed a £2 billion buyback through mid-2026 and expects 70 pence per share in 2026 dividends. The European Commission approved Nucala for certain COPD patients. China accepted GSK’s regulatory filing for its RSV vaccine Arexvy.
February 15, 2026
1 21 22 23 24 25 27